Le Lézard
Classified in: Health
Subjects: PDT, FDA

icotec ag Receives FDA Clearance for the Ř 4.5mm VADER® Pedicle Screws


ALTSTAETTEN, Switzerland, Jan. 24, 2023 /PRNewswire/ -- icotec ag, the leading medical device manufacturer of Carbon/PEEK spinal implants, announces the U.S. Food and Drug Administration (FDA) 510(k) clearance to market the VADER® Pedicle System inclusive of Ř 4.5 mm pedicle screws and extended long Carbon/PEEK rods made from BlackArmor®. 

icotec expands its VADER® Pedicle System with the world's first Ř 4.5 mm Carbon/PEEK screw and extended rod portfolio in the US market, allowing more patients access to optimal spine tumor treatment.

The extended VADER® Pedicle System maintains its proven indication and versatility for open, MIS and cement-augmented surgical techniques while providing additional options for stabilizing the upper-thoracic region of the spine.

"60% of metastatic tumors occur in the thoracic spine1". We are extremely proud that icotec is the world-leading provider of extended solutions for the stabilization of this frequently affected spinal region with the extension of its VADER® product family with canulated and fenestrated Ř 4.5 mm pedicle screws and longer rod options. An important milestone that represents our continued commitment to develop and commercialize spinal implants made from radiolucent BlackArmor®, expanding treatment options and allowing for safer tumor care," said Roger Stadler, CEO of icotec ag.

Radiolucent BlackArmor® implants broaden therapeutic options for patients with spinal tumors. Lateral x-ray of the thoracic spine, stabilized with VADER® Pedicle System ? courtesy of Naresh Kumar, Singapore.

Radiolucent BlackArmor® implants broaden therapeutic options for patients with spinal tumors. Lateral x-ray of the thoracic spine, stabilized with VADER® Pedicle System ? courtesy of Naresh Kumar, Singapore.

The VADER® Pedicle System is now consisting of pedicle screws of diameters between 4.5 and 7.5 mm in lengths of 25 to 60 mm, and rods in different shapes up to 300 mm in length. VADER® screws and rods are made of unique BlackArmor® Carbon/PEEK composite material. BlackArmor® offers excellent stabilization of the spine while being completely radiolucent, allowing for clear visualization in postoperative imaging, improved radiation planning and dose delivery, and expanding treatment options for patients with spinal tumors.

About icotec ag

Founded in 1999, icotec ag is a family-owned SME based in Altstaetten, Switzerland. icotec develops, manufactures, and distributes spinal implants made from radiolucent and artifact-free BlackArmor®. icotec's proprietary BlackArmor® material is made up of continuous carbon fibers combined with PEEK and is processed with icotec's unique manufacturing technology. With 20 years of clinical success and more than 50,000 implanted products, icotec ag is a pioneer in cutting-edge spinal tumor therapy.

For further information, visit our website (www.icotec-medical.com)

1Wewel JT, O'Toole JE: Epidemiology of Spinal Cord and Column Tumors. Neurooncol Pract. 2020 Nov 18;7(Suppl 1):i5-i9. doi: 10.1093/nop/npaa046. PMID: 33299568; PMCID: PMC7705531. 

SOURCE icotec ag


These press releases may also interest you

at 11:31
The FLCCC Alliance today announced Lynne Kristensen will step into the newly created senior director, communications role leading global public relations and media strategy for the organization. She will also oversee the FLCCC's new international...

at 11:26
Louis Hernandez Jr., Founder and Chairman of the Board of the Foundation, proudly announces the promotion of Gina Rogoto to the position of Senior Vice President of Programs and Operations at Louis Hernandez Jr.'s Foundation For A Bright Future ("For...

at 11:25
Medical Solutions, which connects nurses and allied health clinicians with hospitals and healthcare systems, has released findings from its annual Voices of Care survey. One key finding reveals that only 42.8% of respondents feel they are paid fairly...

at 11:18
Bioretec Ltd is pleased to announce that Mr. Alan Donze has been appointed CEO of Bioretec as of today, 20 May 2024. He will start in this position immediately. With a distinguished career spanning the banking and medical device industries, Mr. Donze...

at 11:16
Omeza®, a regenerative skincare company that develops marine-based therapies for the treatment of chronic wounds, recently presented in vivo data showing that OCMtm wound matrix alone...

at 11:10
As part of its plan to bring more doctors to West Central Florida, the region's top health care system today announced that it will soon launch BayCare Health System's first surgery residency program. The Accreditation Council for Graduate Medical...



News published on and distributed by: